![](/img/cover-not-exists.png)
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides
Madeleine Duvic, Matthew L. Sherman, Gary S. Wood, Timothy M. Kuzel, Elise Olsen, Francine Foss, Robert J. Laliberté, John L. Ryan, Kristilyn Zonno, Alain H. RookVolume:
55
Year:
2006
Language:
english
DOI:
10.1016/j.jaad.2006.06.038
File:
PDF, 137 KB
english, 2006